Dashboard
Explore Stocks
Pricing
About
Sign Up
Summary
Intrinsic Value
Fundamental Analysis
Wall Street Estimates
Dividend Analysis
Competition
Ownership
News
Profile Summary
Financials
Income Statement
Balance Sheet
Cash Flow
DCF Valuation
Earnings Call
Dividends
Wall Street Estimates
Read Financial Reports
Teva Pharmaceutical Industries Limited TEVA
Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - IL
Watchlist
$ 16.43
-1.91 %
$ 18.6 B
Market Cap
-19.33
P/E
Price Target
Average
29.84%
Revenue Forecast
Estimate
1.94%
EBIT
Estimate
--71.48%
Net Income
Estimate
102.27%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Teva Pharmaceutical Industries Limited
Wall Street analysts predict an average 1-year price target for
TEVA
of
$21.3
, with forecasts ranging from a low of
$14
to a high of
$26
.
TEVA Lowest Price Target
Wall Street Target
14 USD
-14.79%
TEVA Average Price Target
Wall Street Target
21.3 USD
29.84%
TEVA Highest Price Target
Wall Street Target
26 USD
58.25%
REVENUE FORECAST
Revenue Forecast Chart
TEVA
EBIT FORECAST
EBIT Forecast Chart
TEVA
NET INCOME FORECAST
Net Income Chart
TEVA
Upgrade a Plan
If you need more info, please check
Pricing Guidelines
.
Premium Plan
Enough to check your investmentsfrom time to time.
$
9.00
/ month
15 stocks per week
Enough to check investments
Select Plan
Unlimited Plan
No restrictions, no limits.All stocks, all tools.
$
15.00
/ month
All stocks, all tools.
No restrictions, no limits.
Select Plan